YOUR SEARCH FOR Text 27 RESULTS
21 of Total
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Derm
… to be highlighted -Featured abstracts for ruxolitinib cream (Opzelura ® ) and povorcitinib … p.m. MT ) ePoster Exhibits Atopic Dermatitis Ruxolitinib Cream Improves Patient-Reported …
22 of Total
Portfolio: MPNs & GVHD, Hematology/Oncology, Dermatology & Inflammation and Autoimmunity
… Close Hematology Close Open MPNs Jakafi ® (ruxolitinib) 1 JAK1/JAK2 Myelofibrosis 2 , polycythemia vera 2 status for mobile MPNs ruxolitinib XR (QD) JAK1/JAK2 Bioequivalence and …
23 of Total
State Disclosures | Incyte.com
… condition) shall also be provided. Jakafi ® (ruxolitinib) Disclosure Form Monjuvi ® … (axatilimab-csfr) Disclosure Form Opzelura ® (ruxolitinib) Disclosure Form Pemazyre ® …
24 of Total
Inflammation and Autoimmunity Research: Immune-Mediated Dermatologic Conditions | Incyte.Com
… of the U.S. Learn more about Opzelura ® (ruxolitinib) cream For Patients For HCPs Medical … (1-855-463-3463). Learn more about Opzelura ® (ruxolitinib) cream For HCPs Global Medical …
25 of Total
Company Statements | Incyte.com
… 2022 Corporate Statement Regarding Opzelura™ (ruxolitinib) Cream November 2, 2021 Incyte … 2020 Data from Investigator Initiated Study of Ruxolitinib in Patients with Severe COVID-19 …
26 of Total
Hematology and Oncology Research | Incyte.com
… of the U.S. Learn more about Jakafi ® (ruxolitinib) For Patients For HCPs Learn more …
27 of Total
From A Small Team of Research Scientists, Chemists & Biologists | Incyte.com
… called LIMBER. LIMBER was designed to evaluate ruxolitinib combination strategies—as well as …